Click to copy
Click to copy

Akcea Therapeutics: 2Q Earnings Snapshot

August 6, 2019

BOSTON (AP) _ Akcea Therapeutics Inc. (AKCA) on Tuesday reported a loss of $37.3 million in its second quarter.

On a per-share basis, the Boston-based company said it had a loss of 40 cents.

The results fell short of Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 38 cents per share.

The biopharmaceutical company posted revenue of $26.6 million in the period.

Akcea Therapeutics shares have fallen 32% since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $20.46, a decline of 40% in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AKCA at https://www.zacks.com/ap/AKCA

All contents © copyright 2019 The Associated Press. All rights reserved.